SEC Form 3 · accession 0001823381-26-000012
Alamar Biosciences, Inc. · ALMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L. Brottem
Officer — General Counsel
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002104204
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.